CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval.  CinCor’s focus is on cardiovascular, metabolic and kidney diseases.  CinCor Pharma, Inc. was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in 2018.

Biopharmaceuticals